Dementia associated with Parkinson's disease

[1]  D. Aarsland,et al.  A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[2]  H. Braak,et al.  Cognitive status correlates with neuropathologic stage in Parkinson disease , 2005, Neurology.

[3]  M. Hely,et al.  Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years , 2005, Movement disorders : official journal of the Movement Disorder Society.

[4]  M. Yahr,et al.  Dementia in idiopathic Parkinson's disease , 1986, Journal of Neural Transmission.

[5]  U P Mosimann,et al.  Visual perception in Parkinson disease dementia and dementia with Lewy bodies , 2004, Neurology.

[6]  Günther Deuschl,et al.  Rivastigmine for dementia associated with Parkinson's disease. , 2004, The New England journal of medicine.

[7]  Dag Aarsland,et al.  Role of Cholinesterase Inhibitors in Parkinson’s Disease and dementia with Lewy Bodies , 2004, Journal of geriatric psychiatry and neurology.

[8]  T. Robbins,et al.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. , 2004, Brain : a journal of neurology.

[9]  N. Bohnen,et al.  Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. , 2003, Archives of neurology.

[10]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[11]  Murat Emre,et al.  What causes mental dysfunction in Parkinson's disease? , 2003, Movement disorders : official journal of the Movement Disorder Society.

[12]  M. Okun,et al.  Visual-spatial ability in Parkinson's disease. , 2003, Frontiers in bioscience : a journal and virtual library.

[13]  G. E. Smith,et al.  Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism , 2003, Neurology.

[14]  P. Hof,et al.  Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease , 2003, Acta Neuropathologica.

[15]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[16]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[17]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[18]  K. Marder,et al.  The association of incident dementia with mortality in PD , 2002, Neurology.

[19]  D. Aarsland.  Galantamine for Parkinson's disease with dementia , 2002, European Neuropsychopharmacology.

[20]  Yaakov Stern,et al.  Combined effect of age and severity on the risk of dementia in Parkinson's disease , 2002, Annals of neurology.

[21]  D. Aarsland,et al.  Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[22]  G. Lenzi,et al.  Donepezil in the treatment of hallucinations and delusions in Parkinson’s disease , 2002, Neurological Sciences.

[23]  K. Marder,et al.  Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study , 2002, Movement disorders : official journal of the Movement Disorder Society.

[24]  H. Braak,et al.  Parkinson’s disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology , 2002, Neurobiology of Aging.

[25]  V. Lerner,et al.  Successful Use of Donepezil for the Treatment of Psychotic Symptoms in Patients With Parkinson's Disease , 2002, Clinical neuropharmacology.

[26]  K. Jellinger,et al.  Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease , 2002, Journal of Neural Transmission.

[27]  G. Halliday,et al.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. , 2002, Brain : a journal of neurology.

[28]  M. Brin,et al.  Drugs to treat dementia and psychosis , 2002 .

[29]  Joseph E Parisi,et al.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. , 2002, Archives of neurology.

[30]  H. Hanyu,et al.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. , 2002, AJNR. American journal of neuroradiology.

[31]  John A Lee.  For personal use. Only reproduce with permission from The Lancet Publishing Group. , 2002 .

[32]  I G McKeith,et al.  Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial , 2001, Movement disorders : official journal of the Movement Disorder Society.

[33]  Glenda M. Halliday,et al.  Cortical Lewy body pathology in the diagnosis of dementia , 2001, Acta Neuropathologica.

[34]  G. Glosser.  Neurobehavioral aspects of movement disorders. , 2001, Neurologic clinics.

[35]  D. Aarsland,et al.  Risk of dementia in Parkinson’s disease: A community-based, prospective study , 2001 .

[36]  J. Cummings,et al.  Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease , 2001, International journal of geriatric psychiatry.

[37]  G. Pezzoli,et al.  Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease , 2001, Neurological Sciences.

[38]  B. Pfefferbaum,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. , 2001 .

[39]  Murat Emre,et al.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.

[40]  Douglas Galasko,et al.  Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study , 2000, International journal of geriatric psychiatry.

[41]  D. Dickson,et al.  Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease , 2000, Acta Neuropathologica.

[42]  G. Glosser,et al.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease , 2000, Neurology.

[43]  K. Jellinger.  Pathology of Parkinsonism , 2000, Neurobiology of Aging.

[44]  H. Ross,et al.  A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease , 2000, Neurology.

[45]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.

[46]  R. Howard,et al.  Donepezil for the treatment of psychosis in dementia with Lewy bodies , 2000, International journal of geriatric psychiatry.

[47]  L. Thal,et al.  Cholinergic dysfunction in diseases with Lewy bodies , 2000, Neurology.

[48]  E. Perry,et al.  Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. , 1999, The American journal of psychiatry.

[49]  P. Jäkälä,et al.  The α2 agonist, clonidine, improves spatial working memory performance in Parkinson's disease , 1999, Neuroscience.

[50]  P. Hobson,et al.  The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test. , 1999, Age and ageing.

[51]  O. Lopez,et al.  Dementia with Lewy bodies , 1998, Neurology.

[52]  C. Tanner,et al.  Early dopaminergic drug-induced hallucinations in parkinsonian patients , 1998, Neurology.

[53]  K. Rockwood,et al.  Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients , 1998, International Psychogeriatrics.

[54]  D. Dickson,et al.  Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease , 1998, Acta Neuropathologica.

[55]  K. Marder,et al.  Postmenopausal estrogen use and Parkinson's disease with and without dementia , 1998, Neurology.

[56]  Y. Agid,et al.  Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist. , 1998, Clinical neuropharmacology.

[57]  J. Chapman,et al.  Apolipoprotein E4 in Parkinson Disease and Dementia: New Data and Meta‐Analysis of Published Studies , 1998, Alzheimer disease and associated disorders.

[58]  R. Albin,et al.  Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[59]  K. Jellinger.  Morphological substrates of dementia in parkinsonism. A critical update. , 1997, Journal of neural transmission. Supplementum.

[60]  P. Scheltens,et al.  rCBF SPECT in Parkinson's disease patients with mental dysfunction. , 1997, Journal of neural transmission. Supplementum.

[61]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[62]  G. Broe,et al.  A longitudinal of Parkinson's disease: clinical and neuropsychological correlates of dementia , 1996, Journal of Clinical Neuroscience.

[63]  M. Hutchinson,et al.  Cholinesterase inhibition in Parkinson's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[64]  S. Minoshima,et al.  In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease , 1996, Annals of neurology.

[65]  J. Cummings,et al.  Frequency of dementia in Parkinson disease. , 1996, Archives of neurology.

[66]  H. Soininen,et al.  Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia , 1996, Neurology.

[67]  H. Braak,et al.  New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease. , 1996, Journal of neural transmission. Supplementum.

[68]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[69]  K. Marder,et al.  Neuropsychological characteristics of preclinical dementia in Parkinson's disease , 1995, Neurology.

[70]  K. Marder,et al.  The frequency and associated risk factors for dementia in patients with Parkinson's disease. , 1995, Archives of neurology.

[71]  R. Ravid,et al.  ‘Lewy body disease’: clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia , 1995, Clinical Neurology and Neurosurgery.

[72]  B. Dubois,et al.  [Cognitive functions and the basal ganglia: the model of Parkinson disease]. , 1994, Revue neurologique.

[73]  J. Growdon,et al.  The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease , 1994, Neurology.

[74]  H. Tachibana,et al.  Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimensional surface display with 123I-iodoamphetamine. , 1993, Dementia.

[75]  R. Mayeux,et al.  Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. , 1993, Archives of neurology.

[76]  T. Robbins,et al.  Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. , 1993, Brain : a journal of neurology.

[77]  K. Marder,et al.  Antecedent clinical features associated with dementia in Parkinson's disease , 1993, Neurology.

[78]  Y. Agid,et al.  Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. , 1993, Archives of neurology.

[79]  A. Lees,et al.  A clinicopathologic study of 100 cases of Parkinson's disease. , 1993, Archives of neurology.

[80]  E. Perry,et al.  Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease , 1993, Alzheimer disease and associated disorders.

[81]  Werner Paulus,et al.  Clinico-pathological correlations in Parkinson's disease , 1992, Clinical Neurology and Neurosurgery.

[82]  M Schulzer,et al.  Cerebral glucose metabolism in Parkinson's disease with and without dementia. , 1992, Archives of neurology.

[83]  D. Galasko,et al.  Lewy body disease. , 1992, Current opinion in neurology and neurosurgery.

[84]  N. Nishitani,et al.  SPECT findings in Parkinson's disease associated with dementia. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[85]  K. Marder,et al.  A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. , 1992, Archives of neurology.

[86]  Murray Grossman,et al.  Sentence comprehension in Parkinson's disease: The role of attention and memory , 1992, Brain and Language.

[87]  H. Mayberg,et al.  A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[88]  P. Ince,et al.  Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease , 1991, Annals of the New York Academy of Sciences.

[89]  H. Tachibana,et al.  Cerebral Blood Flow and Dementia in Parkinson's Disease , 1991, Journal of geriatric psychiatry and neurology.

[90]  M. Grossman,et al.  Sentence comprehension and praxis deficits in Parkinson's disease , 1991, Neurology.

[91]  M C Bourdel,et al.  (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[92]  K. Marder,et al.  Are demented patients with Parkinson's disease accurately reflected in prevalence surveys? A survival analysis , 1991, Neurology.

[93]  Y. Agid,et al.  Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy , 1991, Neurology.

[94]  W. Weiner,et al.  Visuospatial impairment in Parkinson's disease , 1991, Neurology.

[95]  I. Litvan,et al.  Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[96]  K. Marder,et al.  An estimate of the incidence of dementia in idiopathic Parkinson's disease , 1990, Neurology.

[97]  Bruno Dubois,et al.  Cholinergic deficiency and frontal dysfunction in Parkinson's disease , 1990, Annals of neurology.

[98]  D. Mann,et al.  Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome , 1990, Neuroscience Letters.

[99]  Y. Stern,et al.  Cognitive change following MPTP exposure , 1990, Neurology.

[100]  H. Soininen,et al.  Different error pattern of episodic and semantic memory in Alzheimer's disease and Parkinson's disease with dementia , 1989, Neuropsychologia.

[101]  S. Huber,et al.  Neuropsychological differences between the dementias of Alzheimer's and Parkinson's diseases. , 1989, Archives of neurology.

[102]  G. Paulson,et al.  Magnetic resonance imaging in dementia of Parkinson's disease. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[103]  J. Rinne,et al.  Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra , 1989, Annals of neurology.

[104]  F Lhermitte,et al.  Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? , 1989, Journal of neurology, neurosurgery, and psychiatry.

[105]  P. Caffarra,et al.  Dementia and cognitive impairment in Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[106]  M. Yoshimura,et al.  Lewy body disease with and without dementia: a clinicopathological study of 35 cases. , 1988, Clinical neuropathology.

[107]  J. Saint-Cyr,et al.  Procedural learning and neostriatal dysfunction in man. , 1988, Brain : a journal of neurology.

[108]  H. Soininen,et al.  Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases , 1988, Annals of neurology.

[109]  K. Marder,et al.  An estimate of the prevalence of dementia in idiopathic Parkinson's disease. , 1988, Archives of neurology.

[110]  H. Teräväinen,et al.  The effect of age of disease onset on neuropsychological performance in Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[111]  J. Cummings,et al.  Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates , 1988, Journal of geriatric psychiatry and neurology.

[112]  Y. Agid,et al.  Dementia in Parkinson’s Disease , 1988 .

[113]  Cummings Jl.  The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type. , 1988 .

[114]  H. Teräväinen,et al.  Dementia and treatment with L‐dopa in Parkinson's disease , 1988, Movement disorders : official journal of the Movement Disorder Society.

[115]  J. Cummings.  The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type. , 1988, European neurology.

[116]  S. Iversen,et al.  Handbook of Psychopharmacology , 1988, Springer US.

[117]  H. Shulman,et al.  Fluctuations in plasma dopamine level impair memory in Parkinson's disease , 1987, Neurology.

[118]  F Lhermitte,et al.  Cholinergic‐dependent cognitive deficits in Parkinson's disease , 1987, Annals of neurology.

[119]  L. Kurland,et al.  A case‐control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease , 1987, Neurology.

[120]  E. Perry,et al.  Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases. , 1987, Journal of neural transmission. Supplementum.

[121]  G. Goldenberg,et al.  Impairment of motor planning in patients with Parkinson's disease: evidence from ideomotor apraxia testing. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[122]  F Lhermitte,et al.  Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease , 1986, Neurology.

[123]  Y. Stern,et al.  Intellectual changes in patients with MPTP‐induced parkinsonism , 1985, Neurology.

[124]  E. Perry,et al.  Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[125]  R. Mayeux,et al.  Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. , 1984, Archives of neurology.

[126]  F. Boller,et al.  Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. , 1984, Archives of neurology.

[127]  I. Nakano,et al.  Parhnson’s Disease: Neuron Loss in the Nucleus Basah Without Concomitant Alzheimer’s Disease , 2004 .

[128]  Yves Agid,et al.  A subcortico-cortical cholinergic system is affected in Parkinson's disease , 1983, Brain Research.

[129]  Y. Agid,et al.  Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.

[130]  E. Perry,et al.  Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases , 1983, Journal of the Neurological Sciences.

[131]  D L Price,et al.  Basal forebrain neurons in the dementia of Parkinson disease , 1983, Annals of neurology.

[132]  R. Mayeux,et al.  Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[133]  P. Yates,et al.  The pathology of the human locus ceruleus. , 1983, Clinical neuropathology.

[134]  R. Mindham,et al.  A controlled study of dementia in Parkinson's disease. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[135]  G. Zappala,et al.  Mental deterioration, visuoperceptive disabilities and constructional apraxia in Parkinson's disease , 1982, Acta neurologica Scandinavica.

[136]  S Fahn,et al.  “Tip‐of‐the‐tongue” phenomenon in Parkinson disease , 1982, Neurology.

[137]  J. Mortimer,et al.  Relationship of motor symptoms to intellectual deficits in Parkinson disease , 1982, Neurology.

[138]  L. Heston.  Dementia associated with Parkinson's disease: a genetic study. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[139]  U. Roessmann,et al.  Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations , 1980, Annals of neurology.

[140]  U. Rinne,et al.  EPIDEMIOLOGY of PARKINSON'S DISEASE IN FINLAND , 1976, Acta neurologica Scandinavica.

[141]  R. Loewenson,et al.  Parkinson's disease , 1973, Neurology.

[142]  O. Sacks,et al.  Effects of levodopa in parkinsonian patients with dementia , 1972, Neurology.